With this launch, the company intends to revolutionize Obstructive Airway Disease (OAD) diagnosis, in line with its ambition to strengthen its position as the lung leader in India. This is a part of the Company’s 'LungAttack' campaign that endeavors to drive awareness about COPD and encourage early diagnosis.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3ovfrl4
via IFTTT
0 comments:
Post a Comment